 10 PM / in 11 minutes BRIEF-Kala Pharmaceuticals Announces NDA For Inveltystm Accepted By U.S. FDA Reuters Staff 1 Min Read 
Jan 5 (Reuters) - Kala Pharmaceuticals Inc: 
* KALA PHARMACEUTICALS ANNOUNCES NEW DRUG APPLICATION FOR INVELTYSTM (KPI-121 1%) HAS BEEN ACCEPTED FOR REVIEW BY THE U.S. FOOD AND DRUG ADMINISTRATION 
* KALA PHARMACEUTICALS INC - BRAND NAME FOR KPI-121 1%, INVELTYS, HAS BEEN CONDITIONALLY APPROVED BY FDA 
* KALA PHARMA-FDA INDICATES APPLICATION FOR INVELTYSTM SUFFICIENTLY COMPLETE TO PERMIT SUBSTANTIVE REVIEW,SET PDUFA TARGET ACTION DATE OF AUGUST 24,2018â€‹ Source text for Eikon: Further company coverage: